U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C11H9NO4
Molecular Weight 219.1939
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NIVIMEDONE

SMILES

CC1=C(C)C=C2C(O)=C(C(=O)C2=C1)[N+]([O-])=O

InChI

InChIKey=JXGBXHHEYIRNGA-UHFFFAOYSA-N
InChI=1S/C11H9NO4/c1-5-3-7-8(4-6(5)2)11(14)9(10(7)13)12(15)16/h3-4,13H,1-2H3

HIDE SMILES / InChI
Sodium nivimedone (BRL10833) is an orally administered anti-allergic agent with similar properties to DSCG. Nivimedone inhibited IgE-mediated passive cutaneous anaphylactic (PCA) reactions in the rat and the antigen-induced release of histamine from human lung passively sensitized with atopic serum. The pharmacological potency of sodium nivimedone when compared to DSCG was 42 times greater in the human lung system and approximately ten times greater in rat PCA. In addition, single doses of sodium nivimedone given by mouth inhibited antigen-induced bronchoconstriction in man.

Approval Year

PubMed

PubMed

TitleDatePubMed
The orally administered anti-allergic agent, sodium nivimedone (BRL 10833); efficacy in bronchial asthma and effects on IgE, complement and eosinophils.
1979-07
Peritoneal anaphylaxis in the rat after sensitization with mouse antiserum.
1978

Sample Use Guides

In Vivo Use Guide
Sodium nivimedone (BRL10833) given at an oral dose of 200 mg thrice daily, was compared, after a preliminary standardization week, with placebo in a 6-week double-blind cross-over trial.
Route of Administration: Oral
In Vitro Use Guide
Nivimedone (BRL10833) increases cAMP at a relatively high dose (10(-4) M) in guinea pig ileum.
Name Type Language
1H-INDENE-1,3(2H)-DIONE, 5,6-DIMETHYL-2-NITRO-, ION(1-)
Preferred Name English
NIVIMEDONE
INN  
INN  
Official Name English
nivimedone [INN]
Common Name English
5,6-DIMETHYL-2-ACI-NITRO-1,3-INDANDIONE
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C29714
Created by admin on Mon Mar 31 18:33:23 GMT 2025 , Edited by admin on Mon Mar 31 18:33:23 GMT 2025
Code System Code Type Description
MESH
C012136
Created by admin on Mon Mar 31 18:33:23 GMT 2025 , Edited by admin on Mon Mar 31 18:33:23 GMT 2025
PRIMARY
PUBCHEM
76966940
Created by admin on Mon Mar 31 18:33:23 GMT 2025 , Edited by admin on Mon Mar 31 18:33:23 GMT 2025
PRIMARY
EVMPD
SUB09333MIG
Created by admin on Mon Mar 31 18:33:23 GMT 2025 , Edited by admin on Mon Mar 31 18:33:23 GMT 2025
PRIMARY
FDA UNII
1M887244YI
Created by admin on Mon Mar 31 18:33:23 GMT 2025 , Edited by admin on Mon Mar 31 18:33:23 GMT 2025
PRIMARY
CAS
49561-92-4
Created by admin on Mon Mar 31 18:33:23 GMT 2025 , Edited by admin on Mon Mar 31 18:33:23 GMT 2025
PRIMARY
EPA CompTox
DTXSID80197841
Created by admin on Mon Mar 31 18:33:23 GMT 2025 , Edited by admin on Mon Mar 31 18:33:23 GMT 2025
PRIMARY
INN
4114
Created by admin on Mon Mar 31 18:33:23 GMT 2025 , Edited by admin on Mon Mar 31 18:33:23 GMT 2025
PRIMARY
NCI_THESAURUS
C84021
Created by admin on Mon Mar 31 18:33:23 GMT 2025 , Edited by admin on Mon Mar 31 18:33:23 GMT 2025
PRIMARY
CAS
838868-56-7
Created by admin on Mon Mar 31 18:33:23 GMT 2025 , Edited by admin on Mon Mar 31 18:33:23 GMT 2025
ALTERNATIVE
SMS_ID
100000084125
Created by admin on Mon Mar 31 18:33:23 GMT 2025 , Edited by admin on Mon Mar 31 18:33:23 GMT 2025
PRIMARY